According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...

Just weeks after announcing a deal to sell its antibiotics manufacturing in the U.S. to Neopharma, India’s Dr. Reddy’s Laboratories says it will now unload its API manufacturing business in Jeedimetla ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's ...

EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.

The main market opportunities lie in enhancing supply chain resilience, reducing production costs and cycle times, and supporting environmental sustainability. The integration of continuous ...

Olon S.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, announced today the acquisition of a local ...

TIANJIN, China, May 31, 2019 /PRNewswire/ -- Asymchem, a leading custom manufacturer of Intermediates and API's for the pharmaceutical industry, today announced that its Dunhua 1 site, a small ...

Six months after Merck & Co.'s manufacturing operations were crippled by a global cyberattack, the company says it has mostly recovered from the computer hack that took out its API production and ...

The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...